Show simple item record

dc.contributor.authorZhou, Tong
dc.contributor.authorGarcia, Joe G.N.
dc.contributor.authorZhang, Wei
dc.date.accessioned2011-05-27T02:31:11Z
dc.date.available2011-05-27T02:31:11Z
dc.date.issued2011-04
dc.identifier.bibliographicCitationZhou, T., Garcia, J. G., & Zhang, W. 2011. Integrating microRNAs into a system biology approach to acute lung injury. Translational Research, 157(4): 180-190. DOI: 10.1016/j.trsl.2011.01.010en
dc.identifier.issn1931-5244
dc.identifier.otherDOI: 10.1016/j.trsl.2011.01.010
dc.identifier.urihttp://hdl.handle.net/10027/7699
dc.descriptionNOTICE: this is the author’s version of a work that was accepted for publication in Translational Research. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Translational Research, [VOL 157, ISSUE 4, (April 2011)] DOI: 10.1016/j.trsl.2011.01.010.en
dc.description.abstractAcute lung injury (ALI), including the ventilator-induced lung injury (VILI) and the more severe acute respiratory distress syndrome (ARDS), are common and complex inflammatory lung diseases potentially affected by various genetic and non-genetic factors. Using the candidate gene approach, genetic variants associated with immune response and inflammatory pathways have been identified and implicated in ALI. Since gene expression is an intermediate phenotype that resides between DNA sequence variation and higher level cellular or whole-body phenotypes, the illustration of gene expression regulatory networks could potentially enhance understanding of disease susceptibility and the development of inflammatory lung syndromes. MicroRNAs (miRNAs) have emerged as a novel class of gene regulators which play critical roles in complex diseases including ALI. Comparisons of global miRNA profiles in animal models of ALI and VILI identified several miRNAs (e.g., miR-146a, miR-155) previously implicated in immune response and inflammatory pathways. Therefore, via regulation of target genes in these biological processes and pathways, miRNAs potentially contribute to the development of ALI. While this line of inquiry exists at a nascent stage, miRNAs have the potential to be critical components of a comprehensive model for inflammatory lung disease built by a systems biology approach that integrates genetic, genomic, proteomic, epigenetic as well environmental stimuli information. Given their particularly recognized role in regulation of immune and inflammatory responses, miRNAs also serve as novel therapeutic targets and biomarkers for ALI/ARDS or VILI, thus facilitating the realization of personalized medicine for individuals with acute inflammatory lung disease.en
dc.description.sponsorshipThis work was supported by HL 58064, HL 94394.en
dc.language.isoen_USen
dc.publisherElsevieren
dc.subjectmicroRNAen
dc.subjectacute lung injuryen
dc.subjectmechanical ventilationen
dc.subjectinflammationen
dc.subjectimmune responseen
dc.subjectgene expressionen
dc.subjectgenomicsen
dc.titleIntegrating microRNAs into a system biology approach to acute lung injuryen
dc.title.alternativeMicroRNAs in Acute Lung Injuryen
dc.typeArticleen


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record